MedTrace Logo

Russian Disc Degeneration Study

NCT04600544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1070

Last updated 2024-12-24

No results posted yet for this study

Summary

The main aim of this study is to establish disease-oriented biobank to facilitate research in biology of the lumbar disc degeneration. Diverse biological samples (whole blood, plasma, disc tissue) along with MRI imaging, clinical, socio-demographic and various omics data (e.g. genomic and transcriptomic) will be available for researchers and clinicians for a variety of further multi-omics studies. It will lay the groundwork for the development of early diagnostics of DDD and its personalized treatment.

The study is planned to enroll up to 1,100 patients with different grades of lumbar disc degeneration. It is planned to recruit patients within 36 months.

Conditions

  • Intervertebral Disc Degeneration
  • Genetic Predisposition to Disease

Interventions

OTHER

Non-interventional

Translational, observational study

Sponsors & Collaborators

  • Institute of Cytology and Genetics

    collaborator UNKNOWN

  • Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan

    collaborator OTHER_GOV

  • N.N. Priorov National Medical Research Center of Traumatology and Orthopedics

    collaborator OTHER

  • Novosibirsk State University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-16
Primary Completion
2022-10-19
Completion
2024-12-10

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04600544 on ClinicalTrials.gov